Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions

March 10, 2015 updated by: University Hospital, Basel, Switzerland
The purpose of this study is to use functional MRI (fMRI) and magnetic resonance (MR) diffusion tensor imaging (DTI) to investigate brain activation and white matter changes in patients with congenital (birth defect of the spinal column), acute and chronic complete spinal cord lesions. The findings of this study may provide a basis to better understand the pathomechanisms underlying the dynamic neurofunctional changes following a spinal cord lesions in man. This understanding is important for the improvement of existing therapies and for the development of new therapeutic approaches.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Recently new approaches to spinal cord repair have been successfully established in animal models. Promising therapies for promoting spinal axonal regeneration in man will be available in the near future. Most research in the field is focussed on the lesion itself and the perilesional spinal cord. The recovery of motor and sensory function is,however, not permitted by local processes at the spinal level only. The whole central nervous system (CNS) reacts to such a condition. Therefore the modulation of motor and sensory function in spinal cord lesioned patients should be reflected in characteristic changes of cortical brain activity, which are accessible to new non-invasive functional neuroimaging techniques such as functional magnetic resonance imaging (fMRI). Changes of white matter due to axonal damage can also be measured qualitatively and quantitatively using MR diffusion tensor imaging (DTI). Those measures may provide a basis to better understand the pathophysiology underlying spinal cord lesions in man, including changes in brain function over time (during rehabilitation) or related to specific treatment. However, there are no studies available yet addressing those topics or providing mechanism-based approaches for determining the time interval of application of novel neuroregenerative drugs. By investigation of brain activation and white matter changes in patients with congenital(myelomeningocele (MMC)), acute and chronic spinal cord lesions (ASIA A) first and fundamental work in this field will be conducted in this study.

Study Type

Observational

Enrollment (Actual)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basle, Switzerland
        • University Hospital, Basle (only study site!)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  • Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A
  • Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12) ASIA A
  • Volunteers without any neurological deficits

Description

Inclusion criteria:

  • Paraplegic patients (Th1-Th12, ASIA A),
  • Myelomeningocele patients (Th1-Th12 ASIA A)
  • Acute SCI 2-6 months, chronic SCI 12-24 months

Exclusion criteria:

  • Traumatic brain injury (TBI)
  • Neurological diseases other than spinal cord lesion
  • MRI incompatibility
  • Pressure sores
  • methicillin-resistant Staphylococcus aureus (MRSA)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic posttraumatic paraplegia
Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A, spinal cord injury (SCI) 12-24 months
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
Acute posttraumatic paraplegia
Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A,SCI 2-6 months,
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
Myelomeningocele patients
Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12) ASIA A
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
Volunteers
Volunteers without any neurological deficits
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Christoph Stippich, Prof, University Hospital, Basle - Department of Neuroradiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

October 1, 2013

Study Registration Dates

First Submitted

September 23, 2010

First Submitted That Met QC Criteria

September 23, 2010

First Posted (Estimate)

September 24, 2010

Study Record Updates

Last Update Posted (Estimate)

March 11, 2015

Last Update Submitted That Met QC Criteria

March 10, 2015

Last Verified

March 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myelomeningocele

Clinical Trials on fMRI, DTI

Subscribe